Startups
We are pioneering a new therapeutic approach to treat debilitating ear, nose and throat (ENT) diseases that impact the lives of millions of people.
Overview
Location
United States, Massachusetts, Watertown
Total raised
$59.5M
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Perceptive Advisors | perceptivelife.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Sep 26, 2018 | Funding round | $29.5M |
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 2, 2025 | Wall Street drifts closer to records as oil prices jump and US manufacturing slumps | The past weekend’s attacks by Ukraine in Russia, meanwhile, helped to raise uncertainty about the flow of oil and gas around the world. Monday’s market moves also came after more harsh rhetoric crossed between the world’s two largest econom... |
| Feb 3, 2020 | Lyra Therapeutics Closes $30M Series C Financing | Lyra Therapeutics, Inc., a Watertown, Mass.-based clinical-stage therapeutics company, completed a $30m Series C financing. The round was led by Perceptive Advisors with participation from Clifton Capital as well as participation by existin... |
| Feb 3, 2020 | Daily funding roundup - February 3th, 2020 | Baton Systems raised $4M; LoanStreet landed $5M; Doubtnut secured $15M; Rimilia picks up $15M Scaled Robotics: Scaled Robotics’s industrial robots aim to navigate construction sites and produce 3D maps of them in minutes. Scaled Robotics ha... |
| Jan 29, 2020 | Lyra Therapeutics Completes $30 Million Series C | WATERTOWN, Mass.--(BUSINESS WIRE)--Lyra Therapeutics, Inc., a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ... |
| Sep 26, 2018 | Lyra Therapeutics raises $29.5M for chronic rhinosinusitis drug implant | Perceptive Advisors led the financing, while new investors RA Capital management, ArrowMark Partners and Soleus Capital participated, along with existing investors Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partn... |
| Sep 26, 2018 | Lyra Therapeutics Raises $29.5M in Series B Financing | Lyra Therapeutics, Inc. (fka 480 Biomedical, Inc.), a Watertown, Mass.-based clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT) diseases, raised $29.5m in Series B equity financ... |
| Sep 26, 2018 | Lyra Therapeutics Announces $29.5 Million Series B | Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT) diseases, announced today a $29.5 million Series B equity financing. Proceeds from the financing wi... |
| Lyra Therapeutics raises $29.5M for chronic rhinosinusitis drug implant | A drugmaker with a product candidate for a sinus inflammation disease has raised an equity financing round to move it into mid-stage clinical development. Watertown, Massachusetts-based Lyra Therapeutics said Wednesday that it had raised $2... |
Reviews 0
FAQ about Lyra Therapeutics
How much funding has Lyra Therapeutics raised?
Lyra Therapeutics has raised $59.5M in total across 2 funding rounds.
What funding rounds has Lyra Therapeutics raised?
Parsers VC lists 2 funding rounds of Lyra Therapeutics, among them a funding round of $29.5M on Sep 26, 2018.
Who has invested in Lyra Therapeutics?
Parsers VC lists 2 investors of Lyra Therapeutics, among them Perceptive Advisors.
What has the press written about Lyra Therapeutics?
Parsers VC has collected 9 articles mentioning Lyra Therapeutics, among them “Wall Street drifts closer to records as oil prices jump and US manufacturing slumps” (Jun 2, 2025) and “Lyra Therapeutics Closes $30M Series C Financing” (Feb 3, 2020).
Is Lyra Therapeutics still active?
Yes, Lyra Therapeutics is active; its latest activity on Parsers VC dates from Jun 2, 2025.